Literature DB >> 22072753

Polyfunctional T cells accumulate in large human cytomegalovirus-specific T cell responses.

Raskit Lachmann1, Martha Bajwa, Serena Vita, Helen Smith, Elizabeth Cheek, Arne Akbar, Florian Kern.   

Abstract

Large cytomegalovirus (CMV)-specific CD8 T-cell responses are observed in both young and, somewhat more often, old people. Frequent CMV reactivation is thought to exhaust these cells and render them dysfunctional so that larger numbers of them are needed to control CMV. Expansions of CMV-specific CD4 T cells are also seen but are less well studied. In this study, we examined the T-cell response to the dominant CMV pp65 and IE-1 antigens in healthy CMV-infected people across a wide age range (20 to 84 years) by using multicolor flow cytometry. CMV-specific T cells were characterized by the activation markers CD40 ligand (CD40L), interleukin-2 (IL-2), tumor necrosis factor alpha (TNF-α), and gamma interferon (IFN-γ) and the memory markers CD27 and CD45RA. The proportions of effector memory T cells increased in large responses, as did the proportions of polyfunctional CD8 (IFN-γ(+) IL-2(+/-) TNF-α(+)) and CD4 (CD40L(+/-) IFN-γ(+) IL-2(+) TNF-α(+)) T-cell subsets, while the proportion of naïve T cells decreased. The bigger the CD4 or CD8 T-cell response to pp65, the larger was the proportion of T cells with an advanced memory phenotype in the entire (including non-CMV-specific) T-cell compartment. In addition, the number of activation markers per cell correlated with the degree of T-cell receptor downregulation, suggesting increased antigen sensitivity in polyfunctional cells. In summary, our findings show that polyfunctional CMV-specific T cells were not superseded by dysfunctional cells, even in very large responses. At the same time, however, the memory subset composition of the entire T-cell compartment correlated with the size of the T-cell response to CMV pp65, confirming a strong effect of CMV infection on the immune systems of some, but not all, infected people.

Entities:  

Mesh:

Substances:

Year:  2011        PMID: 22072753      PMCID: PMC3255847          DOI: 10.1128/JVI.00873-11

Source DB:  PubMed          Journal:  J Virol        ISSN: 0022-538X            Impact factor:   5.103


  50 in total

1.  Dysfunctional CMV-specific CD8(+) T cells accumulate in the elderly.

Authors:  Qin Ouyang; Wolfgang M Wagner; Wei Zheng; Anders Wikby; Ed J Remarque; Graham Pawelec
Journal:  Exp Gerontol       Date:  2004-04       Impact factor: 4.032

2.  The cytomegalovirus-specific CD4+ T-cell response expands with age and markedly alters the CD4+ T-cell repertoire.

Authors:  Batoul Pourgheysari; Naeem Khan; Donna Best; Rachel Bruton; Laxman Nayak; Paul A H Moss
Journal:  J Virol       Date:  2007-04-04       Impact factor: 5.103

Review 3.  Similarities and differences in CD4+ and CD8+ effector and memory T cell generation.

Authors:  Robert A Seder; Rafi Ahmed
Journal:  Nat Immunol       Date:  2003-09       Impact factor: 25.606

4.  PD-1 expression and IL-2 loss of cytomegalovirus- specific T cells correlates with viremia and reversible functional anergy.

Authors:  U Sester; D Presser; J Dirks; B C Gärtner; H Köhler; M Sester
Journal:  Am J Transplant       Date:  2008-07       Impact factor: 8.086

5.  Latent cytomegalovirus infection amplifies CD8 T-lymphocyte mobilisation and egress in response to exercise.

Authors:  James E Turner; Sarah Aldred; Oliver C Witard; Mark T Drayson; Paul M Moss; Jos A Bosch
Journal:  Brain Behav Immun       Date:  2010-07-16       Impact factor: 7.217

6.  Age-associated accumulation of CMV-specific CD8+ T cells expressing the inhibitory killer cell lectin-like receptor G1 (KLRG1).

Authors:  Qin Ouyang; Wolfgang M Wagner; David Voehringer; Anders Wikby; Tatjana Klatt; Steffen Walter; Claudia A Müller; Hanspeter Pircher; Graham Pawelec
Journal:  Exp Gerontol       Date:  2003-08       Impact factor: 4.032

7.  Cellular responses to cytomegalovirus in immunosuppressed patients: circulating CD8+ T cells recognizing CMVpp65 are present but display functional impairment.

Authors:  M Engstrand; A K Lidehall; T H Totterman; B Herrman; B-M Eriksson; O Korsgren
Journal:  Clin Exp Immunol       Date:  2003-04       Impact factor: 4.330

8.  Phenotypic and functional separation of memory and effector human CD8+ T cells.

Authors:  D Hamann; P A Baars; M H Rep; B Hooibrink; S R Kerkhof-Garde; M R Klein; R A van Lier
Journal:  J Exp Med       Date:  1997-11-03       Impact factor: 14.307

9.  Effect of ageing on CMV-specific CD8 T cells from CMV seropositive healthy donors.

Authors:  María Luisa Pita-Lopez; Inmaculada Gayoso; Olga DelaRosa; Javier G Casado; Corona Alonso; Elisa Muñoz-Gomariz; Raquel Tarazona; Rafael Solana
Journal:  Immun Ageing       Date:  2009-08-28       Impact factor: 6.400

10.  T cell recognition patterns of immunodominant cytomegalovirus antigens in primary and persistent infection.

Authors:  Naeem Khan; Donna Best; Rachel Bruton; Laxman Nayak; Alan B Rickinson; Paul A H Moss
Journal:  J Immunol       Date:  2007-04-01       Impact factor: 5.422

View more
  52 in total

1.  Cytomegalovirus-Responsive CD8+ T Cells Expand After Solid Organ Transplantation in the Absence of CMV Disease.

Authors:  L E Higdon; J Trofe-Clark; S Liu; K B Margulies; M K Sahoo; E Blumberg; B A Pinsky; J S Maltzman
Journal:  Am J Transplant       Date:  2017-03-13       Impact factor: 8.086

2.  Characterizing the Cellular Immune Response to Parainfluenza Virus 3.

Authors:  Paibel I Aguayo-Hiraldo; Reuben J Arasaratnam; Ifigeneia Tzannou; Manik Kuvalekar; Premal Lulla; Swati Naik; Caridad A Martinez; Pedro A Piedra; Juan F Vera; Ann M Leen
Journal:  J Infect Dis       Date:  2017-07-15       Impact factor: 5.226

3.  IFNγ⁻TNFα⁻IL2⁻MIP1α⁻CD107a⁺PRF1⁺ CD8 pp65-Specific T-Cell Response Is Independently Associated With Time to Death in Elderly Humans.

Authors:  Sara Ferrando-Martínez; Ezequiel Ruiz-Mateos; Joseph P Casazza; Rebeca S de Pablo-Bernal; Beatriz Dominguez-Molina; M Ángeles Muñoz-Fernández; Juan Delgado; Rafael de la Rosa; Rafael Solana; Richard A Koup; Manuel Leal
Journal:  J Gerontol A Biol Sci Med Sci       Date:  2014-09-18       Impact factor: 6.053

Review 4.  Cytomegalovirus memory inflation and immune protection.

Authors:  Luka Cicin-Sain
Journal:  Med Microbiol Immunol       Date:  2019-04-10       Impact factor: 3.402

5.  Interleukin-2 from Adaptive T Cells Enhances Natural Killer Cell Activity against Human Cytomegalovirus-Infected Macrophages.

Authors:  Zeguang Wu; Giada Frascaroli; Carina Bayer; Tatjana Schmal; Thomas Mertens
Journal:  J Virol       Date:  2015-04-08       Impact factor: 5.103

6.  T helper type 1 polarizing γδ T cells and Scavenger receptors contribute to the pathogenesis of Pemphigus vulgaris.

Authors:  Dayasagar Das; Vivek Anand; Sujay Khandpur; Vinod K Sharma; Alpana Sharma
Journal:  Immunology       Date:  2017-10-12       Impact factor: 7.397

7.  Human Cytomegalovirus Decreases Major Histocompatibility Complex Class II by Regulating Class II Transactivator Transcript Levels in a Myeloid Cell Line.

Authors:  Praneet K Sandhu; Nicholas J Buchkovich
Journal:  J Virol       Date:  2020-03-17       Impact factor: 5.103

Review 8.  Age-related changes in CD8 T cell homeostasis and immunity to infection.

Authors:  Janko Nikolich-Žugich; Gang Li; Jennifer L Uhrlaub; Kristin R Renkema; Megan J Smithey
Journal:  Semin Immunol       Date:  2012-05-01       Impact factor: 11.130

9.  Recognition and killing of autologous, primary glioblastoma tumor cells by human cytomegalovirus pp65-specific cytotoxic T cells.

Authors:  Smita K Nair; Gabriel De Leon; David Boczkowski; Robert Schmittling; Weihua Xie; Janet Staats; Rebecca Liu; Laura A Johnson; Kent Weinhold; Gary E Archer; John H Sampson; Duane A Mitchell
Journal:  Clin Cancer Res       Date:  2014-03-21       Impact factor: 12.531

10.  Immunotherapeutic strategies to prevent and treat human herpesvirus 6 reactivation after allogeneic stem cell transplantation.

Authors:  Ulrike Gerdemann; Laura Keukens; Jacqueline M Keirnan; Usha L Katari; Chinh T Q Nguyen; Anne P de Pagter; Carlos A Ramos; Alana Kennedy-Nasser; Stephen M Gottschalk; Helen E Heslop; Malcolm K Brenner; Cliona M Rooney; Ann M Leen
Journal:  Blood       Date:  2012-11-14       Impact factor: 22.113

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.